EMA: Validity of GMP and GDP certificates extended
The European medicines regulatory network has announced the automatically applied extension of the validity of GMP and GDP certificates for sites in the EEA (European Economic Area) until the end of 2022, unless there are restrictions on the validity period stated in the clarifying remarks of the certificate. This extension also applies to time-limited manufacturing and import and wholesale authorisations.
The Q&A guidance document has been adapted, accordingly:
Question 2.2 concerning the extension of certificates was updated, three new questions 4.2-4.4 regarding pharmacovigilance activities were added.
Source:
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.
You may also be interested in the following articles:
